DENVER
03/18/2010 05:12 am ET Updated May 25, 2011

Inviragen completes merger with $15M investment

Inviragen Inc., a Colorado developer of vaccines, has merged with a Singapore company in tandem with a $15 million equity investment from a group of venture capital investors.

Read more on Denver Business Journal